6-O-and N-sulfated syndecan-1 promotes baculovirus binding and entry into mammalian cells

Journal of Virology

Volumn 87, Issue 20, 2013, Pages 11148-11159

  Makkonen, Kaisa Emilia ^a   Paula Turkki, ^b   Laakkonen, Johanna P ^a   Ylä Herttuala, Seppo ^a,c   Marjomäki, Varpu ^b   Airenne, Kari J ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN; PROTEOHEPARAN SULFATE; SYNDECAN 1; SYNDECAN 2; SYNDECAN 4;

ARTICLE; BACULOVIRUS; BINDING AFFINITY; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SULFATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS INHIBITION;

BACULOVIRIDAE; CELL LINE; HUMANS; RECEPTORS, VIRUS; SULFATES; SYNDECAN-1; TRANSDUCTION, GENETIC; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84886913005     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01919-13     Document Type: Article

References (64)

1. Airenne KJ, Mahonen AJ, Laitinen OH, Yla-Herttuala S. 2009. Baculovirus- mediated gene transfer: an emerging universal concept, p 263-291. In Templeton, N(ed), Gene and cell therapy: therapeutic mechanisms and strategies, 3rd ed. CRC Press, Boca Raton, FL.
2. Hartig PC, Cardon MC, Kawanishi CY. 1992. Effect of baculovirus on selected vertebrate cells. Dev. Biol. Stand. 76:313-317.
3. Kost TA, Condreay JP, Jarvis DL. 2005. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat. Biotechnol. 23:567-575.
4. Airenne KJ, Makkonen K-E, Mähönen AJ, Ylä-Herttuala S. 2010. In vivo application and tracking of baculovirus. Curr. Gene Ther. 10:187-194.
5. Airenne KJ, Hu Y-C, Kost TA, Smith RH, Kotin RM, Ono C, Matsuura Y, Wang S, Ylä-Herttuala S. 2013. Baculovirus: an insectderived vector for diverse gene transfer applications. Mol. Ther. 21: 739-749.
6. O'Reilly DR, Miller LK, Luckov VA. 1994. Baculovirus expression vectors: a laboratory manual. Oxford University press, New York, NY.
7. Kost TA, Condreay JP. 2002. Innovations-biotechnology: baculovirus vectors as gene transfer vectors for mammalian cells: biosafety considerations. J. Am. Biol. Safety Assoc. 7:167-169.
8. Burges HD, Croizier G, Huger J. 1980. A review of safety tests on baculoviruses. Entomaphaga 25:329-339.
9. Hu Y-CC. 2008. Baculoviral vectors for gene delivery: a review. Curr. Gene Ther. 8:54-65.
10. Airenne KJ, Laitinen OH, Mähönen AJ, Ylä-Herttuala S. 2009. Transduction of vertebrate cells with recombinant baculovirus. Cold Spring Harbor protocols 2009:pdb.prot5182. doi:10.1101/pdb.prot5182.
11. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. 1995. Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc. Natl. Acad. Sci. U. S. A. 92:10099-10103.
12. Boyce FM, Bucher NL. 1996. Baculovirus-mediated gene transfer into mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 93:2348-2352.
13. Condreay JP, Witherspoon SM, Clay WC, Kost TA. 1999. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc. Natl. Acad. Sci. U. S. A. 96:127-132.
14. Song SU, Shin S-H, Kim S-K, Choi G-S, Kim W-C, Lee M-H, Kim S-J, Kim I-H, Choi M-S, Hong Y-J, Lee K-H. 2003. Effective transduction of osteogenic sarcoma cells by a baculovirus vector. J. Gen. Virol. 84:697-703. doi:10.1099/vir.0.18772-0.
15. Chen C-Y, Lin C-Y, Chen G-Y, Hu Y-C. 2011. Baculovirus as a gene delivery vector: recent understandings of molecular alterations in transduced cells and latest applications. Biotechnol. Adv. 29:618-631.
16. Laakkonen JP, Makela AR, Kakkonen E, Turkki P, Kukkonen S, Peranen J, Yla-Herttuala S, Airenne KJ, Oker-Blom C, Vihinen-Ranta M, Marjomaki V, Mäkelä AR, Peränen J, Ylä-Herttuala S, Marjomäki V. 2009. Clathrin-independent entry of baculovirus triggers uptake of E. coli in non-phagocytic human cells. PLoS One 4:e5093.
17. Laakkonen JP, Kaikkonen MU, Ronkainen PHA, Ihalainen TO, Niskanen EA, Häkkinen M, Salminen M, Kulomaa MS, Ylä-Herttuala S, Airenne KJ, Vihinen-Ranta M. 2008. Baculovirus-mediated immediateearly gene expression and nuclear reorganization in human cells. Cell. Microbiol. 10:667-681.
18. Kukkonen SP, Airenne KJ, Marjomaki V, Laitinen OH, Lehtolainen P, Kankaanpaa P, Mahonen AJ, Raty JK, Nordlund HR, Oker-Blom C, Kulomaa MS, Yla-Herttuala S, Marjomäki V, Kankaanpää P, Mähönen AJ, Räty JK, Ylä-Herttuala S. 2003. Baculovirus capsid display: a novel tool for transduction imaging. Mol. Ther. 8:853-862.
19. Matilainen H, Rinne J, Gilbert L, Marjomaki V, Reunanen H, Oker-Blom C. 2005. Baculovirus entry into human hepatoma cells. J. Virol. 79:15452-15459.
20. Van Loo ND, Fortunati E, Ehlert E, Rabelink M, Grosveld F, Scholte BJ. 2001. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J. Virol. 75:961-970.
21. Wu C, Wang S. 2012. A pH-sensitive heparin-binding sequence from baculovirus gp64 protein is important for binding to mammalian cells but not to Sf9. J. Virol. 86:484-491.
22. Duisit G, Saleun S, Douthe S, Barsoum J, Chadeuf G, Moullier P. 1999. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J. Gene Med. 1:93-102.
23. Tani H, Nishijima M, Ushijima H, Miyamura T, Matsuura Y. 2001. Characterization of cell-surface determinants important for baculovirus infection. Virology 279:343-353.
24. Kataoka C, Kaname Y, Taguwa S, Abe T, Fukuhara T, Tani H, Moriishi K, Matsuura Y. 2012. Baculovirus GP64-mediated entry into mammalian cells. J. Virol. 86:2610-2620.
25. Kamiya K, Kobayashi J, Yoshimura T, Tsumoto K. 2010. Confocal microscopic observation of fusion between baculovirus budded virus envelopes and single giant unilamellar vesicles. Biochim. Biophys. Acta 1798: 1625-1631.
26. Blissard GW. 1996. Baculovirus-insect cell interactions. Cytotechnology 20:73-93.
27. Goley ED, Ohkawa T, Mancuso J, WoodruffJB, D'Alessio JA, Cande WZ, Volkman LE, Welch MD. 2006. Dynamic nuclear actin assembly by Arp2/3 complex and a baculovirus WASP-like protein. Science 314:464-467.
28. Ohkawa T, Volkman LE, Welch MD. 2010. Actin-based motility drives baculovirus transit to the nucleus and cell surface. J. Cell Biol. 190:187-195.
29. Au S, Panté N, Pante N. 2012. Nuclear transport of baculovirus: revealing the nuclear pore complex passage. J. Struct. Biol. 177:90-98.
30. Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030-1037.
31. Mondor I, Ugolini S, Sattentau QJ. 1998. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:3623-3634.
32. Gallay P. 2004. Syndecans and HIV-1 pathogenesis. Microbes Infect. 6:617-622.
33. Cheshenko N, Liu W, Satlin LM, Herold BC. 2007. Multiple receptor interactions trigger release of membrane and intracellular calcium stores critical for herpes simplex virus entry. Mol. Biol. Cell 18:3119-3130.
34. Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, Kirnbauer R. 2003. Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J. Virol. 77:13125-13135.
35. Park PW, Reizes O, Bernfield M. 2000. Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters. J. Biol. Chem. 275:29923-29926.
36. Bernfield M, Gotte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M, Götte M. 1999. Functions of cell surface heparan sulfate proteoglycans. Annu. Rev. Biochem. 68:729-777.
37. Götte M, Gotte M. 2003. Syndecans in inflammation. FASEB J. 17:575-591. doi:10.1096/fj.02-0739rev.
38. Carey DJ. 1997. Syndecans: multifunctional cell-surface co-receptors. Biochem. J. 327(Part 1):1-16.
39. Kim CW, Goldberger OA, Gallo RL, Bernfield M. 1994. Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell 5:797-805.
40. Tkachenko E, Rhodes JM, Simons M. 2005. Syndecans: new kids on the signaling block. Circ. Res. 96:488-500.
41. Chen Y, Gotte M, Liu J, Park PW, Götte M. 2008. Microbial subversion of heparan sulfate proteoglycans. Mol. Cells 26:415-426.
42. Lambaerts K, Wilcox-Adelman SA, Zimmermann P. 2009. The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr. Opin. Cell Biol. 21:662-669.
43. Mähönen AJ, Airenne KJ, Purola S, Peltomaa E, Kaikkonen MU, Riekkinen MS, Heikura T, Kinnunen K, Roschier MM, Wirth T, Ylä-Herttuala S, Mahonen AJ, Yla-Herttuala S. 2007. Post-transcriptional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J. Biotechnol. 131:1-8.
44. Kankaanpaa P, Paavolainen L, Tiitta S, Karjalainen M, Paivarinne J, Nieminen J, Marjomaki V, Heino J, White DJ. 2012. BioImageXD: an open, general-purpose and high-throughput image-processing platform. Nat. Methods 9:683-689.
45. Costes SV, Daelemans D, Cho EH, Dobbin Z, Pavlakis G, Lockett S. 2004. Automatic and quantitative measurement of protein-protein colocalization in live cells. Biophys. J. 86:3993-4003.
46. Chung CS, Hsiao JC, Chang YS, Chang W. 1998. A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate. J. Virol. 72: 1577-1585.
47. Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. 2009. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J. Virol. 83:12714-12724.
48. Keller KM, Brauer PR, Keller JM. 1989. Modulation of cell surface heparan sulfate structure by growth of cells in the presence of chlorate. Biochemistry 28:8100-8107.
49. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757-1765.
50. Zautner AE, Jahn B, Hammerschmidt E, Wutzler P, Schmidtke M. 2006. N-and 6-O-sulfated heparan sulfates mediate internalization of coxsackievirus B3 variant PD into CHO-K1 cells. J. Virol. 80:6629-6636.
51. De Parseval A, Bobardt MD, Chatterji A, Chatterji U, Elder JH, David G, Zolla-Pazner S, Farzan M, Lee TH, Gallay PA. 2005. A highly conserved arginine in gp120 governs HIV-1 binding to both syndecans and CCR5 via sulfated motifs. J. Biol. Chem. 280:39493-39504.
52. Turkki P, Makkonen K-E, Huttunen M, Laakkonen JP, Ylä-Herttuala S, Airenne KJ, Marjomäki V. 2013. Cell susceptibility to baculovirus transduction and echovirus infection is modified byPKCphosphorylation and vimentin organization. J. Virol. [Epub ahead of print.] doi:10.1128/JVI.01004-13.
53. Pajusola K, Gruchala M, Joch H, Luscher TF, Yla-Herttuala S, Bueler H. 2002. Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells. J. Virol. 76:11530-11540.
54. O'Flynn NMJ, Patel A, Kadlec J, Jones IM. 2013. Improving promiscuous mammalian cell entry by the baculovirus Autographa californica multiple nuclear polyhedrosis virus. Biosci. Rep. 33:23-36.
55. Fuki IV, Kuhn KM, Lomazov IR, Rothman VL, Tuszynski GP, Iozzo RV, Swenson TL, Fisher EA, Williams KJ. 1997. The syndecan family of proteoglycans. Novel receptors mediating internalization of atherogenic lipoproteins in vitro. J. Clin. Investig. 100:1611-1622.
56. Fuki IV, Meyer ME, Williams KJ. 2000. Transmembrane and cytoplasmic domains of syndecan mediate a multi-step endocytic pathway involving detergent-insoluble membrane rafts. Biochem. J. 351(Part 3):607-612.
57. Wilsie LC, Gonzales AM, Orlando RA. 2006. Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway. Lipids Health Dis. 5:23.
58. Podyma-Inoue KA, Hara-Yokoyama M, Shinomura T, Kimura T, Yanagishita M. 2012. Syndecans reside in sphingomyelin-enriched lowdensity fractions of the plasma membrane isolated from a parathyroid cell line. PLoS One 7:e32351. doi:10.1371/journal.pone.0032351.
59. Benmerah A, Lamaze C. 2007. Clathrin-coated pits: vive la différence?. Traffic 8:970-982.
60. Chen K, Williams KJ. 2013. Molecular mediators for raft-dependent endocytosis of syndecan-1, a highly conserved, multifunctional receptor. J. Biol. Chem. 288:13988-13999.
61. Teng YH, Aquino RS, Park PW. 2012. Molecular functions of syndecan-1 in disease. Matrix Biol. 31:3-16.
62. Luo W-Y, Shih Y-S, Hung C-L, Lo K-W, Chiang C-S, Lo W-H, Huang S-F, Wang S-C, Yu C-F, Chien C-H, Hu Y-C. 2012. Development of the hybrid Sleeping Beauty: baculovirus vector for sustained gene expression and cancer therapy. Gene Ther. 19:844-851.
63. Wang S, Balasundaram G. 2010. Potential cancer gene therapy by baculoviral transduction. Curr. Gene Ther. 10:214-225.
64. Edgell CJ, McDonald CC, Graham JB. 1983. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 80:3734-3737